Key statistics
On Friday, Alkermes Plc (ALKS:NSQ) closed at 33.16, -9.03% below its 52-week high of 36.45, set on Feb 18, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 33.52 |
|---|---|
| High | 34.27 |
| Low | 33.09 |
| Bid | 33.16 |
| Offer | 35.00 |
| Previous close | 33.29 |
| Average volume | 1.54m |
|---|---|
| Shares outstanding | 165.12m |
| Free float | 162.53m |
| P/E (TTM) | 16.43 |
| Market cap | 5.48bn USD |
| EPS (TTM) | 2.02 USD |
Data delayed at least 15 minutes, as of Feb 13 2026 21:00 GMT.
More ▼
Press releases
- Alkermes plc Completes Acquisition of Avadel Pharmaceuticals plc, Accelerating Entry Into Sleep Medicine Market
- Alkermes to Report Fourth Quarter and Year-End Financial Results on Feb. 25, 2026
- Alixorexton Granted Breakthrough Therapy Designation by U.S. FDA for the Treatment of Narcolepsy Type 1
- Alkermes to Present at the 44th Annual J.P. Morgan Healthcare Conference
- Alkermes to Participate in Two Upcoming Investor Conferences
More ▼
